JIR
OSG

James Investment Research’s Octave Specialty Group OSG Stock Holding History

James Investment Research’s Portfolio OSG Stock Details OSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-88,800
Closed -$1.68M – 714
2017
Q1 		$1.68M Buy
+88,800
New +$1.87M 0.05% 270

Other funds holding OSG

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $52.8B AUM 12.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
EC
EJF Capital Arlington, Virginia $150M AUM 32.63% 1-Year Est. Return
AGC
Alden Global Capital Brandon, Florida $273M AUM 36.07% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

James Investment Research's OSG Position: Q2 2017 in Review

James Investment Research sold out of Octave Specialty Group (OSG) in Q2 2017, closing a stake of 88,800 shares — an estimated $1.68M sold.

James Investment Research first reported a position in OSG in Q1 2017 and held it in 1 quarter. The position peaked at $1.68M in Q1 2017. 129 funds tracked by Wall St. Rank hold OSG as of Q2 2017.

  • James Investment Research reported no remaining Octave Specialty Group position as of Q2 2017 after selling out during the quarter.
  • James Investment Research sold 88,800 Octave Specialty Group shares in Q2 2017, an estimated $1.68M.
  • James Investment Research first reported a position in Octave Specialty Group in Q1 2017 and held it in 1 quarter.
  • James Investment Research's Octave Specialty Group position peaked at $1.68M in Q1 2017.
  • 129 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2017.

Based on James Investment Research's 13F filing for Q2 2017, filed 14 Jul 2017.